Home
>
National Drug Code (NDC)
>
nevirapine
nevirapine - 53104-0166-2 - (nevirapine)
Drug Information of nevirapine
| Product NDC: | 53104-0166 |
| Proprietary Name: | nevirapine |
| Non Proprietary Name: | nevirapine |
| Active Ingredient(s): | 200 mg/1 & nbsp; nevirapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of nevirapine
| Product NDC: | 53104-0166 |
| Labeler Name: | Cipla Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077956 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120522 |
Package Information of nevirapine
| Package NDC: | 53104-0166-2 |
| Package Description: | 60 TABLET in 1 BOTTLE (53104-0166-2) |
NDC Information of nevirapine
| NDC Code | 53104-0166-2 |
| Proprietary Name | nevirapine |
| Package Description | 60 TABLET in 1 BOTTLE (53104-0166-2) |
| Product NDC | 53104-0166 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nevirapine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120522 |
| Marketing Category Name | ANDA |
| Labeler Name | Cipla Limited |
| Substance Name | NEVIRAPINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
